US Halts Support for COVID-19 Vaccines for Children—Are Other Vaccines Next?

One of the leading vaccine specialists at the Centers for Disease Control and Prevention (CDC), Lakshmi Panagiotakopoulos, resigned on June 4th, just a week after Robert F. Kennedy JR announced that the Covid-19 vaccine would no longer be advised for most children and pregnancies.

This declaration prompted several days of uncertainty regarding the availability of the Covid-19 vaccine in the U.S. Although there has not been a significant shift in access, parents may face new challenges when trying to vaccinate their children. Nonetheless, Kennedy’s statement reflects a concerning departure from established public health practices.

“My career in public health and vaccinology began with a deep-seated desire to assist the most vulnerable members of our population. This is not something I can continue in this role,” Reuters reported.

Panagiotakopoulos was part of the Advisory Committee on Immunization Practices (ACIP) since 1964. However, last week, Kennedy, as the highest authority in public health in the country, reversed decades of protocol. “As of today, we are unable to announce that the Covid vaccine for healthy children and pregnant women has been removed from the CDC’s recommended vaccination schedule,” he stated in a video shared on the social media platform X on May 27th.

Despite his directive, the CDC has only made minor modifications to its recommendations regarding the Covid-19 vaccine. Rather than a full endorsement for children, it is now recommended “Based on shared clinical decisions,” meaning parents should consult their doctors prior to making a decision. It remains uncertain how this will impact vaccine access in various situations, but it may complicate obtaining vaccinations for children at pharmacies.

The CDC’s guidance on vaccination during pregnancy is rather unclear as well. The relevant website still recommends Covid-19 shots during pregnancy, noting that “This page will be updated to reflect your new vaccination schedule.”

Kennedy’s declaration also stands in stark contrast to the positions of major public health organizations. Both the American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP) have expressed opposition to this stance.

“The CDC and HHS advise individuals to consult healthcare providers regarding personal medical choices,” a spokesperson for HHS told New Scientist. “Under Secretary Kennedy’s leadership, HHS is re-establishing the connection between doctors and patients.”

However, Linda Eckart of Washington University in Seattle argues that these conflicting messages create confusion for the public, stating, “It opens doors for misinformation and undermines overall confidence in vaccines. I cannot fathom that vaccination rates will not decline.”

Numerous studies have demonstrated the safety and efficacy of Covid-19 vaccinations during adolescence and pregnancy. In fact, Martin McCurry, head of the U.S. Food and Drug Administration, emphasized this in a risk assessment for severe Covid-19 published a week before Kennedy’s announcement, further complicating the government’s public health message.

Kennedy’s announcement aligns with similar community policies in several countries. For instance, Australia and the UK do not recommend the Covid-19 vaccine for children unless they are at high risk of severe illness. Likewise, they advise against Covid-19 vaccinations during pregnancy for those already vaccinated.

Asma Khalil, a member of the UK’s Joint Committee on Vaccination and Immunization, stated that the UK’s choice is informed by a reduced risk from omicron variants, the cost-effectiveness of vaccinations, and high herd immunity. Nevertheless, these variables can differ from one country to another. Eckart notes that the UK population generally has better access to healthcare than that of the U.S. “These evaluations necessitate a meticulous consideration of risks and benefits for the national populace,” Khalil asserts. HHS did not respond to New Scientist regarding whether a similar assessment influenced Kennedy’s decision.

Perhaps the most concerning aspect of Kennedy’s announcement is its circumvention of the expected ACIP vote on proposed revisions to COVID-19 vaccine recommendations, which was slated for later this month. “This method of decision-making—by individual professionals who carefully review conflicts of interest and scrutinize the data—has never occurred in our country,” Eckart emphasizes. “We are traversing uncharted territory,” and she fears that Kennedy’s actions could establish precedents for other vaccine recommendations. “I am aware there are numerous vaccines he has actively opposed,” she continues, recalling Kennedy’s previous denunciations of vaccines linked to autism and false claims regarding the polio vaccine.

“What this implies is that [Kennedy] is undermining established scientific guidelines,” stated Amesh Adalja from Johns Hopkins University.